This is for MS but is obviously of interest to AMN patients. I receive these using Google alerts.
What is interesting is the potential use of nanoparticles to stimulate remylination.
"Dr Su Metcalfe, a University of Cambridge senior research associate based at Addenbrooke’s, has won a £150,000 award which will enable her team to proceed to pre-clinical trials in Nanotechnology.
The award is one of only five given out this year worldwide from major pharmaceutical company, Merck Serono, and the first to a UK scientist.
The technology developed for treatment of MS - an incurable autoimmune disease that attacks the central nervous system - by Dr Metcalfe uses tiny ‘smart’ nanoparticles that act as magic bullets to deliver powerful factors known to increase repair of damaged myelin. The key factor is “LIF”, a stem cell protein."
--------
It's exiting because there is clearly some advanced work going on that could (one-day) help everyone dealing with myelin-related illnesses.
More at cambridge-news.co.uk/Cambri...